ARCHIVES

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 39 No. 34 | September 13, 2013

Download PDF Visit The Full Archive

Related Articles

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude

July 22, 1988

NCI-Approved Clinical Trials

December 30, 2005

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

January 31, 2003